Showing posts with label
KN-024
.
Show all posts
Showing posts with label
KN-024
.
Show all posts
Breakthrough treatment possible new mainstay against lung cancer
›
Immunotherapy drug outperforms chemo in latest trial A recent study comparing the immunotherapy drug pembrolizumab to chemotherapy coul...
›
Home
View web version
